Port Washington, NY 12/19/11—Filtration, separation and purification solutions provider Pall has signed a definitive agreement to acquire ForteBio for an undisclosed amount. ForteBio is a developer of label-free protein analysis instruments, including the Octel products based on BioLayer Interferometry technology. “BioPharmaceuticals continues to be the engine of our Life Sciences business and an important long-term […]
On December 23, President Obama signed into law an omnibus bill that will support the government for the rest of fiscal 2012. The final appropriations bill included funding for the NIH, the Department of Energy (DOE), the Centers for Disease Control and Prevention (CDC), the FDA and the EPA. Like the fiscal 2012 budgets for […]
Global equity markets slumped in 2011 with the exception of the US. The European sovereign debt crisis and natural disasters led the majority of Asia Pacific and European stock indexes down by double digits. US stock markets experienced similar volatility but ended the year with mixed results. Positive earnings reports lifted US equity prices in […]
Pay Invoice
Latest Blogs
-
MOBILion Expands into Proteomics MS Market
April 30, 2026 5:05 pm
-
Carterra Introduces Faster SPR
March 27, 2026 7:26 pm
-
New Report Details Higher Education Science R&D Spending
February 27, 2026 3:23 pm
Sitemap
Your Data and Privacy
About Us
IBO (Instrument Business Outlook) is a twice-monthly newsletter aimed at providing decision-makers with the latest and most complete information available on the life science and analytical instrument industry, and lab product markets. IBO delivers the latest curated industry news, information and trends, as well as SDi data and analysis to deliver the maximum in industry insight with a minimum time investment for executives and investors.
